Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

AMPICILLIN

All products: general benefit

Other products in the same Health Canada class (J01C, J01CA) — coverage varies; not interchangeable

  • Amoxicillin (Novamoxin): general benefit, Not a benefit, Listing status unconfirmed
  • Amoxicillin + clavulanic acid (Clavulin): general benefit, Not a benefit
  • Cloxacillin (Orbenin): general benefit, Not a benefit
  • Penicillin v (Nadopen-V): general benefit, Not a benefit
  • Piperacillin + tazobactam (Tazocin): not a benefit

Novo-Ampicillin · DIN 00020877 · 250mg · capsule

General benefitMarketed · checked 2026-09-20
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Novo-Ampicillin · DIN 00020877 Manufacturer: Novopharm Ltd.; listing date 1996-10-01 Daily cost (source): $1.6892 Health Canada: Marketed since 2015-07-10 · brand TEVA-AMPICILLIN · ATC J01CA01 AMPICILLIN · form Capsule · route Oral · ingredients AMPICILLIN (AMPICILLIN TRIHYDRATE) 250 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Novo-Ampicillin: Formulary list price $0.4223/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4223 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1125 · Verify on the e-Formulary ↗ (DIN 00020877)

Source record
DIN 00020877: Novo-Ampicillin Raw flags: sec3=Y Item: 081216002; group id 27; item number 0055; lccId None; manufacturer id NOP Source form: Cap; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $0.4223; ministry $0.4223 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00020877 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1125
Interchangeable products
Penbritin · DIN 00002003 · not recorded
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (08:12:16 Penicillins) and how they are covered

Matched class: 08:12:16 Penicillins

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): AMOXICILLIN, AMOXICILLIN & CLAVULANIC ACID, CLOXACILLIN, PENICILLIN V (POTASSIUM) 08:12:16 Penicillins

AMOXICILLIN

· 36 products · General benefit (27), Listed, not a benefit (4), Off-Formulary Interchangeable, not an ODB benefit (4), Temporary benefit (1) · strengths: 250mg, 500mg, 125mg, 25mg/mL, 50mg/mL · Cap, Chew Tab, O/L, Pd for Oral Susp

AMOXICILLIN & CLAVULANIC ACID

· 25 products · General benefit (22), Listed, not a benefit (3) · strengths: 25mg & 6.25mg/mL, 50mg & 12.5mg/mL, 200mg & 28.5mg/5mL, 400mg & 57mg/5mL, 250mg & 125mg, 500mg & 125mg, 875mg & 125mg · O/L, Susp, Tab

CLOXACILLIN

· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 250mg, 500mg, 25mg/mL · Cap, O/L

PENICILLIN V (POTASSIUM)

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 25mg/mL, 300mg · O/L, Tab

PIPERACILLIN SODIUM & TAZOBACTAM SODIUM

· 18 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2g & 250mg, 3g & 375mg, 4g & 500mg · Inj Pd-2.25g Vial Pk, Inj Pd-3.375g Vial Pk, Inj Pd-4.5g Vial Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:16
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:24 Tetracyclines, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Indications: The treatment of infections due to susceptible gram-negative organisms (including strains of shigellae, S. typhosa and other salmonellae, E. coli, H. influenzae and P. mirabilis) and susceptible gram positive organisms (including streptococci, pneumococci, and non beta lactamase producing staphylococci). To reduce the development of drug-resistant bacteria and maintain the effectiveness of TEVA- AMPICILLIN and other antibacterial drugs, TEVA-AMPICILLIN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. https://pdf.hres.ca/dpd_pm/00057464.PDF PM date: not printed or not captured Source product: TEVA-AMPICILLIN; DIN 00020877; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.